How many employees does Orchestra BioMed Holdings, Inc. have?

Orchestra BioMed Holdings, Inc. reported 86 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 12, 2026. That is up 22.9% from a year earlier.

What is Orchestra BioMed Holdings, Inc.'s revenue per employee?

Orchestra BioMed Holdings, Inc. brought in $33.5M of revenue in fiscal Dec 2025, which is $389K per employee. That ranks 64 of 108 companies we track in Biotechnology, where the median is $459K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Orchestra BioMed Holdings, Inc. employees and revenue per employee

OBIO · Biotechnology · $356M market cap

Orchestra BioMed Holdings, Inc. had 86 employees at the end of fiscal Dec 2025, up 22.9% from a year earlier. Revenue for the year was $33.5M, up 1169.2% from a year earlier, or $389K per employee. Revenue and headcount both grew, and revenue grew faster.

Employees

+22.9% YoY

Revenue

$33.5M

+1169.2% YoY

Revenue / employee

$389K

Peer median $459K

Rank in industry

64 of 108

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2020

Hover a year for the numbers.

OBIO employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	86	$33.5M	$389K	+22.9%	+1169.2%
Dec 2024	70	$2.6M	$38K	+25.0%	-4.4%
Dec 2023	56	$2.8M	$49K	—	-21.9%
Dec 2020	4	$5.7M	$1.43M	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Orchestra BioMed Holdings, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
FENC Fennec Pharmaceuticals Inc.	35	$44.6M	$1.28M	Hiring into decline
OBIO Orchestra BioMed Holdings, Inc.	86	$33.5M	$389K	Efficient growth
SEPN Septerna Inc	130	$46.0M	$353K	Efficient growth
PTGX Protagonist Therapeutics, Inc.	132	$46.0M	$349K	Hiring into decline
VSTM Verastem, Inc.	102	$30.9M	$303K	Efficient growth
KYMR Kymera Therapeutics, Inc.	238	$39.2M	$165K	Hiring into decline
OCUL Ocular Therapeutix, Inc.	325	$51.8M	$159K	Hiring into decline
CAPR Capricor Therapeutics, Inc.	160	$22.3M	$139K	Hiring into decline
ALMS Alumis Inc.	221	$24.1M	$109K	—

Every Healthcare company

Questions about Orchestra BioMed Holdings, Inc.

How many employees does Orchestra BioMed Holdings, Inc. have?: Orchestra BioMed Holdings, Inc. reported 86 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 12, 2026. That is up 22.9% from a year earlier.
What is Orchestra BioMed Holdings, Inc.'s revenue per employee?: Orchestra BioMed Holdings, Inc. brought in $33.5M of revenue in fiscal Dec 2025, which is $389K per employee. That ranks 64 of 108 companies we track in Biotechnology, where the median is $459K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare OBIO with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Orchestra BioMed Holdings, Inc.'s annual reports (Form 10-K), latest filed March 12, 2026. This is data, not a recommendation to buy or sell OBIO.